ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7819
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy ; volume:14 ; number:1 ; day:3 ; month:5 ; year:2016 ; pages:1-9 ; date:12.2016
World journal of surgical oncology ; 14, Heft 1 (3.5.2016), 1-9, 12.2016
- Creator
-
Incharoen, Pimpin
- Contributor
-
Reungwetwattana, Thanyanan
Saowapa, Sakditad
Kamprerasart, Kaettipong
Pangpunyakulchai, Duangjai
Arsa, Lalida
Jinawath, Artit
SpringerLink (Online service)
- DOI
-
10.1186/s12957-016-0893-6
- URN
-
urn:nbn:de:1111-201605056138
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Incharoen, Pimpin
- Reungwetwattana, Thanyanan
- Saowapa, Sakditad
- Kamprerasart, Kaettipong
- Pangpunyakulchai, Duangjai
- Arsa, Lalida
- Jinawath, Artit
- SpringerLink (Online service)
Other Objects (12)
Pulmonary granulomatous inflammation after ceritinib treatment in advanced ALK-rearranged pulmonary adenocarcinoma
Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung
Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma: a case report
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer
Gingival Metastasis of ALK Rearranged Non-Small Cell Lung Cancer
Successful Treatment of a Resistant Subclone in ALK-Rearranged NSCLC
Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma
Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia
Vulnerability of drug‐resistant EML4‐ALK rearranged lung cancer to transcriptional inhibition
Different Therapeutic Strategies in 2 Young Patients with Advanced ALK-Rearranged Lung Adenocarcinoma: “The Light at the End of the Tunnel”
Transforming tumoroids derived from ALK-positive pulmonary adenocarcinoma to squamous cell carcinoma in vivo
Pulmonary granulomatous inflammation after ceritinib treatment in advanced ALK-rearranged pulmonary adenocarcinoma
Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung
Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma: a case report
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer
Gingival Metastasis of ALK Rearranged Non-Small Cell Lung Cancer
Successful Treatment of a Resistant Subclone in ALK-Rearranged NSCLC
Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma
Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia
Vulnerability of drug‐resistant EML4‐ALK rearranged lung cancer to transcriptional inhibition
Different Therapeutic Strategies in 2 Young Patients with Advanced ALK-Rearranged Lung Adenocarcinoma: “The Light at the End of the Tunnel”
Transforming tumoroids derived from ALK-positive pulmonary adenocarcinoma to squamous cell carcinoma in vivo
Pulmonary granulomatous inflammation after ceritinib treatment in advanced ALK-rearranged pulmonary adenocarcinoma
Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung
Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma: a case report
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer
Gingival Metastasis of ALK Rearranged Non-Small Cell Lung Cancer
Successful Treatment of a Resistant Subclone in ALK-Rearranged NSCLC
Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma
Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia
Vulnerability of drug‐resistant EML4‐ALK rearranged lung cancer to transcriptional inhibition
Different Therapeutic Strategies in 2 Young Patients with Advanced ALK-Rearranged Lung Adenocarcinoma: “The Light at the End of the Tunnel”